Zynnon was founded in the spirit of innovation with an ambitious objective: to offer affordable high-tech connected medical devices, together with associated services, to improve people's health and safety.
Our leadership team brings extensive experience in entrepreneurship, product development, sensor technologies and innovation in healthcare.
Khaled founded Zynnon in 2019 to develop a new generation of affordable medical devices to serve large numbers of people.
Prior to Zynnon, Khaled successfully started and grew his former company (Pulssar Technologies) in the liquid handling area. The company was acquired by Tecan (publicly listed company) in 2017 and Khaled joined the group as Vice President Global Sales in the Partnering Business division.
Before creating Pulssar, Khaled held several positions in engineering, project management and business development at Stago, a key player in the in vitro diagnostic market.
Khaled graduated as an engineer specialising in microtechnology from the French national school of mechanical engineering and microtechnology (ENSMM) and holds multiple patents in the area of laboratory equipment and medical devices. He speaks 5 languages.
Khaled is a two-time winner of the Bpifrance Excellence award and the Deloitte Technology Fast 50 & 500 awards.
Alex has over 25 years of experience in equity capital markets. He spent the bulk of his career in sales and sales management with Morgan Stanley and Bank of America Merrill Lynch, holding senior management and head of division positions in both Switzerland and France. He was also a global relationship manager for key clients in both countries.
Most recently, he was also a member of the executive management board of Bank of America’s Swiss legal entity.
He is a CFA charter holder and has a Master's degree from the University of St. Gallen (Switzerland).
An avid sports fan and enthusiastic skier, Alex serves on the executive board of the elite alpine ski racing division of the Zurich Ski Federation.
Christoph is Zynnon’s Chief Medical Officer (CMO), responsible for the company’s clinical strategy. He oversees the execution of clinical programs and liaises with the technical, scientific and medical communities.
Christoph is Professor of Neurology at the University of Bern and a consultant neurologist at Inselspital, Bern University Hospital.
For almost 20 years, he has been involved as the principal investigator in international and national clinical trials, as well as serving as an advisor for many pharmaceutical companies, and publishing more than 100 original research articles, reviews and book chapters.
After completing his medical training at the University of Heidelberg, University of York, and Columbia University, he specialised in Neurology at the University of Munich with a focus on headache, intensive care medicine, acute neurology, epilepsy, and general neurology.
During a post-doctoral fellowship at the University of California, San Francisco (UCSF), he performed extensive clinical research in human models of migraine and was the first to describe the migraine-related visual disturbance, “visual snow syndrome“.
Juliana is Zynnon’s Office Manager and Head of Communications.
She formerly worked as a HR consultant focusing on recruitment, training and change management. Her previous roles include a talent management position at Total in Paris (France) and, from 2011, positions at small companies in the areas of recruitment, personnel and administrative management.
Juliana graduated in psychology from the University of Paris. She also holds a Master’s degree in Human Resource Management from INSEEC-Paris.
In addition to her work at Zynnon, she is a parenting coach and provides Spanish and Culture courses for children in the canton of Schwyz (Switzerland). Juliana has lived in 5 countries and speaks 4 languages.
Prof. Dr. med. Didier Guillemot is an Advisor to Zynnon.
Prof. Guillemot is a French Doctor specializing in infectious disease, and director of the Pharmacoepidemiology and Infectious Diseases research group at Institut Pasteur (https://www.pasteur.fr). He is also a researcher at Inserm (French National Institute of Health and Medical Research - https://www.inserm.fr).
From May 2016 to September 2017, he was President of Versailles Saint-Quentin-en-Yvelines University (UVSQ - https://www.uvsq.fr), where he has been teaching since 2007.
He received his PhD in technological innovation and public health from the University of Paris-Diderot (https://u-paris.fr) in 1997, going on to obtain an HDR (habilitation to conduct research) in 2003.
Prof. Guillemot was also a member of the Scientific Advisory Board of the Agence Nationale de Sécurité du Médicament et des Produits de Santé (French National Agency for the Safety of Medicines and Health Products - https://ansm.sante.fr) and of the Institut de Veille Sanitaire (French National Public Health Agency - https://www.santepubliquefrance.fr).
Prof. Suzanne Suggs is an Advisor to Zynnon.
Suzanne has over 20 years of experience in health behavior, promotion, communication, and marketing in private industry and academia.
Her work focuses on understanding behavior and acceptance of health prevention measures and then designing solutions to support people’s aim for healthier lives. She has designed, developed, and evaluated IT products and programmes to support self-management, improve prevention behaviors and patient care in many countries and settings.
Suzanne is currently a Professor of Social Marketing at the Università delle Svizzera italiana in Lugano Switzerland, Vice-President of the Swiss School of Public Health, Visiting Reader in the Institute of Global Health Innovation, Faculty of Medicine at Imperial College London, co-speaker of the expert group on Science Communication of the Swiss Academies of Arts and Sciences, and is a member of the Swiss National COVID-19 Science Task Force.
She was a Post-doctoral researcher focused on Healthy Ageing in the Evidence-based Practice Center, Department of Clinical Epidemiology and Biostatistics, at McMaster University. She earned her PhD and a Master of Science in Health Studies from Texas Woman’s University, and a Bachelor of Business Administration in Marketing from the University of North Texas. Previously she was an Assistant Professor of Health Communication at Emerson College and Adjunct Assistant Clinical Professor, Department of Public Health and Family Medicine, at Tufts University School of Medicine.
Gian-Luigi is Zynnon’s Advisor (Innosuisse coach).
Gian-Luigi successfully started and sold a technology based start-up company, active in the Life Science Industry.
In addition, he is member of the board of various start-ups and of FONGIT, Geneva’s hi-tech business incubator.
Gian-Luigi spent more than 10 years as line and general manager in multinational companies and has been an entrepreneur for more than 8 years.
Gian-Luigi holds a degree in economy and marketing (Zurich, Bern), his expertise is in the field of Sales & Marketing, Organization and General Management.
In 2011 he founded More Than A Drop, a not for profit Foundation.
Human welfare shapes our core values. Our primary goal is to give millions of people access to leading-edge products, enabling the physical parameters of the human body to be measured.
Our uncompromising personal ethics underpin everything we do. Honesty, empathy and courage are key values that guide our decisions and drive our actions.
Zynnon has strong
values and high ethical standards.
Khaled and Alex first met on the side of the football pitch where their children were playing. Between them, they have several decades of experience in both traditional entrepreneurship and corporate business.
Zynnon started with the development of a new generation of laboratory products to increase lab efficiency: connected intelligent devices, equipped with a multitude of sensors to measure critical physical parameters from laboratory equipment, during use.
From the onset of the Covid-19 pandemic, the technology used in the field of laboratory devices very quickly proved valuable: with a simple concept for pandemic protection and risk mitigation, the Lieberty product was born.
Our easy to operate, easy to install, affordable solution, to monitor indoor living spaces, gathers data, on a continuous basis, on people’s symptoms (temperature and cough) and immediate environment (air quality, CO2, particles, aerosols).
Installed in individual living spaces in care homes, our smart sensors, in conjunction with our cloud-based artificial intelligence solution, generate a Risk of Infection Index, issue alerts and provide recommendations for corrective action. Lieberty’s ability to detect the risks of respiratory infections (including COVID-19) earlier, helps care homes and their communities to manage the health crisis with greater confidence and efficiency. Thanks to the additional layer of protection provided, care homes can focus on delivering high-quality care with human touch, unhindered by intrusive restrictions on the older people they look after, and their respective families.
Zynnon’s mission is to make its solution accessible to as many people as possible across the world, using leading-edge science and technology to improve lives.
*Our solution is ideal for: Nursing Homes, Home Care, Hospitals.
Microsoft for Startups is a global program dedicated to helping promising tech startups to build their business by offering access to Microsoft technologies and tools including Azure, GitHub, and Microsoft Teams.
Startups in this program also receive technical support and mentorship to help them manoeuvre around roadblocks and can benefit from Microsoft’s global brand, sales teams, and the commercial marketplace to reach more customers.
Swisscom is the leading provider of communication, IT and entertainment in Switzerland. Outside of Switzerland, Swisscom operates Fastweb in Italy. Swisscom has more than 19,000 employees and is one of the most innovative and sustainable companies in Switzerland.
Swisscom offers mobile telecommunications, fixed network, Internet and digital TV solutions for business and residential customers.
Swisscom develops and maintains the wireless and wireline network infrastructure, distribute broadcasting signals and is also active in the banking, energy, entertainment, advertising and healthcare sectors.
InvestHorizon (https://investhorizon.eu) is a programme financed by the European Commission, in association with Eureka, to facilitate Series A funding for selected deep tech companies boosting their investment readiness and investor relations. The first 131 companies selected have already raised over EUR 53 million in equity funding.
The programme is run by a consortium coordinated by Tech Tour with six other partners: BPI France, Meta Group, EurA, BWCON, EBN, and IESE Business School.
Supported by Innosuisse:
Innosuisse is the Swiss Innovation Promotion Agency. It is a federal entity under public law with a separate legal personality. Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Innosuisse especially promotes the partnership between academia and the market with innovation projects, networking, training and coaching, laying the groundwork for successful Swiss start-ups, products and services. It provides considerable benefits for a prosperous and sustainable economy.
CSEM, founded in 1984, is a Swiss research and development center (public-private partnership) specializing in microtechnology, nanotechnology, microelectronics, system engineering, photovoltaics and communications technologies.
More than 500 highly qualified specialists from various scientific and technical disciplines work for CSEM in Neuchâtel, Zurich, Muttenz, Alpnach, and Landquart.